Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Reserpine (SKU N1867): Technical Protocols for Neuropharmaco

    2026-05-21

    Reserpine (SKU N1867): Technical Protocols for Neuropharmacology Research

    What This Product Solves

    Reserpine, chemically identified as methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate (also known as 3,20-Yohimban-16-carboxylic acid derivative), is a bioactive natural product extracted from Rauvolfia plants. In laboratory research, it is widely adopted for neurotransmitter depletion studies, antihypertensive mechanism workflows, and advanced neuropharmacology research. Its utility stems from high purity, well-characterized stability, and consistent depletion of monoamines, essential in modeling neurotransmitter function and hypertension-related pathways. The compound is intended for research use only, supporting reproducible and workflow-consistent protocols where other less-characterized or lower-purity alternatives may introduce confounding variability.

    For foundational guidance on integrating Reserpine into neuropharmacology workflows, see the Technical Guide for Neuropharmacology Labs, which details best practices in neurotransmitter depletion and antihypertensive mechanism studies. Additionally, "Protocol Parameters and Workflow Guidance" provides further procedural recommendations for consistent experimental results.

    Protocol Parameters

    • Solubility (DMSO): ≥13 mg/mL with gentle warming | Compound preparation for stock solutions | Ensures complete dissolution for accurate dosing in cell-based and in vivo assays | Value from product information
    • Storage Conditions: -20°C, sealed, cool, dry | Recommended for long-term compound stability | Maintains high purity and prevents degradation over time | Value from product information
    • Solution Handling: Use freshly prepared solutions; avoid long-term storage | Solution preparation for reproducibility | Reduces risk of activity loss or compound precipitation, critical for sensitive neuropharmacology research | Workflow recommendation
    • Purity: >98.8% (HPLC, NMR confirmed) | Assay consistency and result reproducibility | Minimizes off-target effects and batch-to-batch variability | Value from product information

    Workflow Setup and QC Checklist

    • Inspect the Reserpine vial upon arrival; confirm intact packaging and storage at low temperature (shipped with blue ice for small molecules).
    • Verify compound identity and purity, referencing the provided HPLC and NMR data from APExBIO documentation.
    • Prepare stock solutions in DMSO (≥13 mg/mL), applying gentle warming as needed to achieve full dissolution. Avoid using water or ethanol as solvents due to insolubility.
    • Aliquot stock solutions to minimize freeze-thaw cycles and store aliquots at -20°C in tightly sealed containers.
    • Prepare working dilutions immediately prior to experimental use; discard unused solution at the end of each session to prevent degradation and precipitation.
    • Document lot number, concentration, and storage conditions for each batch to ensure traceability and reproducibility.

    Common Failure Modes and Fixes

    • Incomplete dissolution in DMSO: Apply gentle warming and vortexing; ensure that the stock concentration does not exceed the recommended solubility threshold.
    • Precipitation on storage: Only prepare the amount of solution needed for immediate use. Discard solutions showing visible precipitate or cloudiness.
    • Loss of activity: Avoid repeated freeze-thaw cycles and prolonged storage of diluted solutions. Always use freshly prepared working solutions for each experiment.
    • Potential contamination: Use sterile, non-reactive consumables and work in a clean environment to prevent introduction of impurities that may affect assay results.
    • Batch-to-batch variability: Record and cross-verify lot numbers and purity data; incorporate a reference standard if comparing multiple lots across experiments.

    Scope and Limitations

    Reserpine (SKU N1867) is optimized for use in neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows requiring a well-characterized, high-purity standard. The compound's insolubility in water and ethanol restricts its use to DMSO-based preparations. It is unsuitable for diagnostic, medical, or therapeutic applications, and should not be used in workflows that require clinical validation or patient exposure. The product's potent biological activity demands careful handling and strict adherence to laboratory safety protocols. For applications outside the supported research scope, alternative reagents or validated clinical standards should be considered.

    Conclusion

    Reserpine (SKU N1867) offers a robust, reproducible tool for laboratory-based studies in neurotransmitter depletion, antihypertensive mechanism elucidation, and neuropharmacology. By following the recommended solubility, storage, and solution handling protocols, researchers can ensure consistent experimental outcomes and minimize variability. For further details on technical handling and advanced workflow integration, consult the Reserpine product page and related internal technical articles. Use of this reagent should remain strictly within research settings, with appropriate quality control and safety measures in place.